Liquidia Technologies, Inc. (NASDAQ:LQDA) CAO Dana Boyle Sells 1,063 Shares

Key Points

• Dana Boyle, the Chief Accounting Officer of Liquidia Technologies, sold 1,063 shares of stock on July 28th for a total of $20,771.02, representing a 0.57% decrease in his ownership.
• Liquidia Technologies' stock is currently trading at $19.11, having decreased by 0.8%, with a market capitalization of $1.63 billion.
• Institutional investors now hold 64.54% of Liquidia Technologies' stock, indicating significant interest from larger financial entities.

Liquidia Technologies, Inc. (NASDAQ:LQDA - Get Free Report) CAO Dana Boyle sold 1,063 shares of the business's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $19.54, for a total value of $20,771.02. Following the completion of the transaction, the chief accounting officer directly owned 186,105 shares of the company's stock, valued at approximately $3,636,491.70. This trade represents a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Dana Boyle also recently made the following trade(s):

• On Monday, July 14th, Dana Boyle sold 1,193 shares of Liquidia Technologies stock. The shares were sold at an average price of $14.28, for a total value of $17,036.04.

Liquidia Technologies Stock Down 5.4%

Shares of NASDAQ LQDA traded down $1.01 on Friday, hitting $17.68. The company had a trading volume of 3,309,216 shares, compared to its average volume of 2,404,995. Liquidia Technologies, Inc. has a 12-month low of $8.26 and a 12-month high of $20.33. The business has a 50 day moving average of $15.11 and a two-hundred day moving average of $14.94. The company has a quick ratio of 2.91, a current ratio of 2.93 and a debt-to-equity ratio of 2.08. The firm has a market capitalization of $1.51 billion, a P/E ratio of -11.19 and a beta of 0.14.

Liquidia Technologies (NASDAQ:LQDA - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported ($0.45) earnings per share for the quarter, missing the consensus estimate of ($0.42) by ($0.03). Liquidia Technologies had a negative return on equity of 177.91% and a negative net margin of 903.80%. The company had revenue of $3.12 million during the quarter, compared to analysts' expectations of $3.23 million. As a group, equities research analysts forecast that Liquidia Technologies, Inc. will post -1.51 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on LQDA shares. Raymond James Financial upped their target price on Liquidia Technologies from $27.00 to $29.00 and gave the company a "strong-buy" rating in a research note on Friday, May 9th. Bank of America dropped their target price on Liquidia Technologies from $25.00 to $23.00 and set a "buy" rating for the company in a research note on Wednesday, June 11th. BTIG Research reissued a "buy" rating on shares of Liquidia Technologies in a research report on Tuesday, May 27th. Scotiabank boosted their price target on Liquidia Technologies from $36.00 to $37.00 and gave the company a "sector outperform" rating in a research report on Wednesday, May 28th. Finally, Wall Street Zen raised Liquidia Technologies from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd. One research analyst has rated the stock with a sell rating, one has issued a hold rating, six have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $26.89.

Institutional Investors Weigh In On Liquidia Technologies

Several institutional investors and hedge funds have recently modified their holdings of LQDA. Corebridge Financial Inc. boosted its holdings in Liquidia Technologies by 2.3% in the fourth quarter. Corebridge Financial Inc. now owns 31,516 shares of the company's stock valued at $371,000 after purchasing an additional 694 shares during the last quarter. Ballentine Partners LLC boosted its holdings in Liquidia Technologies by 10.2% in the second quarter. Ballentine Partners LLC now owns 12,139 shares of the company's stock valued at $151,000 after purchasing an additional 1,119 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Liquidia Technologies by 65.6% in the first quarter. GAMMA Investing LLC now owns 2,961 shares of the company's stock valued at $44,000 after purchasing an additional 1,173 shares during the last quarter. Cetera Investment Advisers boosted its holdings in Liquidia Technologies by 4.3% in the fourth quarter. Cetera Investment Advisers now owns 31,243 shares of the company's stock valued at $367,000 after purchasing an additional 1,277 shares during the last quarter. Finally, Valmark Advisers Inc. boosted its holdings in Liquidia Technologies by 7.4% in the first quarter. Valmark Advisers Inc. now owns 18,641 shares of the company's stock valued at $275,000 after purchasing an additional 1,283 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company's stock.

Liquidia Technologies Company Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).